Biotechnology — Ancillary materials present during the production of cellular therapeutic products — Part 2: Best practice guidance for ancillary material suppliers
This document provides guidance for ancillary material (AM) suppliers to maintain a high level of lot-to-lot consistency in the aspects of identity, purity, stability, biosafety, performance, as well as the accompanying documentation.
This document is applicable to cellular therapeutic products, including gene therapy products whereby cells form part of the final product. It does not apply to products without cells.
The AMs described in this document include those of biological origin [e.g. sera, media (including media additives), growth factors, and monoclonal antibodies] and chemical origin. This document does not address dimethyl sulfoxide (DMSO) for cryopreservation, beads, scaffolds, feeder cells, apparatus and instruments, or additives used post bioprocessing.
This document does not cover the selection, assessment or control of starting materials and excipients.
NOTE International, regional or national regulations or requirements can also apply to specific topics covered in this document.
|Get this standard||Prices exclude GST|
|PDF ( Single user document)||
Keep me up-to-dateSign up to receive updates when there are changes to this standard
BS EN 12075:1997
Biotechnology. Large scale process and production. Procedures for fermentation and downstream processes
BS EN 12128:1998
Biotechnology. Laboratories for research, development and analysis. Containment levels of microbiology laboratories, areas of risk, localities and physical safety requirements
BS EN 12296:1998
Biotechnology. Equipment. Guidance on testing procedures for cleanability
BS EN 12297:1998
Biotechnology. Equipment. Guidance on testing procedures for sterilizability